RAFAEL HOLDINGS, INC. Amortization of Deferred Property Taxes
RAFAEL HOLDINGS, INC. (RFL) reported Amortization of Deferred Property Taxes of $212.00 thousand for the 12-month period ending 2022-07-31, per its 10-K filed 2022-10-31.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfDeferredPropertyTaxes · last filed 2022-10-31
- RAFAEL HOLDINGS, INC. amortization of deferred property taxes for the quarter ending 2022-07-31 was $0.00.
- RAFAEL HOLDINGS, INC. amortization of deferred property taxes for the quarter ending 2022-04-30 was $0.00, a 100.00% decline year-over-year.
- RAFAEL HOLDINGS, INC. amortization of deferred property taxes for the quarter ending 2021-07-31 was $0.00.
- RAFAEL HOLDINGS, INC. amortization of deferred property taxes for the quarter ending 2021-04-30 was $37.00K.
- RAFAEL HOLDINGS, INC. amortization of deferred property taxes for fiscal 2022 was $212.00K, a 472.97% increase from fiscal 2021.
- RAFAEL HOLDINGS, INC. amortization of deferred property taxes for fiscal 2021 was $37.00K.
| Period end | Amortization of Deferred Property Taxes 3 month | Amortization of Deferred Property Taxes 6 month | Amortization of Deferred Property Taxes 9 month | Amortization of Deferred Property Taxes 12 month |
|---|---|---|---|---|
| 2022-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31 | $0.00 derived: sum of 2 quarters · filed 2022-10-31 | $212.00K 10-K · filed 2022-10-31 | |
| 2022-04-30 | $0.00 10-Q · filed 2022-06-14 | $212.00K 10-Q · filed 2022-06-14 | ||
| 2021-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31 | $37.00K derived: sum of 2 quarters · filed 2022-10-31 | $37.00K 10-K · filed 2022-10-31 | |
| 2021-04-30 | $37.00K 10-Q · filed 2022-06-14 | $37.00K 10-Q · filed 2022-06-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |